Keywords: avanir, shares, rocket, fda, appeal, pays, off

Avanir shares rocket as FDA appeal pays off

Article | 04 November 1999

Print This

Avanir Pharmaceuticals, which has spent months trying to get approvalfor its oral-facial herpes drug docosanol in the USA, looks to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in